← Back to Clinical Trials
Recruiting NCT03704207
Utility of PCD Diagnostics to Improve Clinical Care
Trial Parameters
Condition Primary Ciliary Dyskinesia
Sponsor Vanderbilt University Medical Center
Study Type INTERVENTIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 1 Year
Max Age N/A
Start Date 2017-06-01
Completion 2028-06-01
Interventions
nNO testing
Brief Summary
This is a study evaluating the utility of current Primary Ciliary Dyskinesia (PCD) diagnostic tests, including nasal nitric oxide testing.
Eligibility Criteria
Inclusion Criteria: * Referred to center for PCD diagnosis considerations * Ability to perform study procedures * Age greater than 2 years of age Exclusion Criteria: * Age less than 2 years of age Inability to perform informed consent